APPLICATION OF IN SILICO STUDIES TARGETING TELOMERIC G-QUADRUPLEX COMPLEX BY PERYLENE DIIMIDES FOR ANTICANCER THERAPY

Hemalatha Cn; Vijey Aanandhi M

doi:10.22159/ajpcr.2018.v11s4.31680

Authors

Hemalatha Cn Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies, Chennai, Tamil Nadu, India.
Vijey Aanandhi M Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology an Advanced Studies, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.22159/ajpcr.2018.v11s4.31680

Keywords:

AutoDock, G-Quadruplex ligand database, Docking, Perylene derivatives

Abstract

Objective: Telomerase enzyme which is expressed in detectable levels and its mechanism was that it increases the length when it binds to telomeres. This eventually leads to extension of lifespan of cells and also makes an attractive target for cancer therapy. Perylene diimides bind to telomerase with duplex genomic DNA, and these G-quadruplex ligands are of responsible for binding affinity with respective proteins. Based on the IC50 values of perylene diimides, QSAR has been studied out and the results are elaborated in preliminary research works. From the results of QSAR, the selected perylene ligands are selected for docking choosing telomerase as a target/protein. From the results of in silico studies, new compounds are designed and synthesized accordingly. Now, the objective of the study was to dock the final synthesized compounds with the telomerase protein to study regarding the pKi value using G-quadruplex ligand database (G4LDB). The docked results are visualized using Discovery Studio Visualizer 4.1. The results are compared with the standard N,N'-bis-(2-(1-piperidino)ethyl)-3,4,9,10-perylene tetracarboxylic acid diimide (PIPER) drug and these compounds will be effective for anticancer therapy.

Methods: The study was to investigate the docking results of synthesized perylene compounds with the results from G4LDB and visualized by Discovery Studio 4.1 Visualizer. The telomerase proteins selected for the study were extracted from Protein Data Bank, and the proteins selected for the study are 3SC8 and 3CE5. Among the compounds (R1, R2, R3, and R4) screened in G-Quadruplex Ligand Database, compound R3 shows better binding affinity with good pKi value as well the interactions with the protein and ligand show better affinity with the targets and these are compared with the standard drug PIPER drug.

Results: Compound R3 possesses the best binding affinity with the target 3CE5 and 3SC8 which shows that the compound will be effective for anticancer therapy.

Downloads

Download data is not yet available.

References

Banu S, Bollu R, Bantu R, Nagarapu L, Polepalli S, Jain N, et al. Design, synthesis and docking studies of novel 1,2-dihydro-4-hydroxy-2-oxoquinoline-3-carboxamide derivatives as a potential anti-proliferative agents. Eur J Med Chem 2017;125:400-10.

Hemalatha C,Vijey M, Aanandhi VM. G-Quadruplex ligands as stabilizer targeting telomerase as anti-cancer agents. Asian J Pharm Clin Res 2017;10:50-3.

Hemalatha C, Muthukumar V. Application of 3D QSAR and docking studies in optimization of perylene diimides as anti-cancer agent. Indian J Pharm Educ Res 2018;52:666-75.

Hemalatha C, Aanandhi MV. 3D QSAR and docking study of perylene-di imides analogues as potent apoptosis inducer and efficacious anticancer agent. Indian Drugs 2017;54:15-27.

Hemalatha C, Aanandhi MV. Synthesis of some novel perylene di imides and evaluation of their anti cancer activity. Asian J Pharm Clin Res 2018;11:1-9.

Marco DI, Antonio A, Rodriguez RA, Balasubramanian S. Experimental approaches to identify cellular G-quadruplex structures and functions. Methods 2012;57:84-2.

Sen D, Gilbert W. Formation of parallel four-stranded complexes by guanine-rich motifs in DNA and its implications for meiosis. Nature 1988;334:364-6.

Davis JT. G-quartets 40 years later: From 5â€™-GMP to molecular biology and supramolecular chemistry. Angew Chem Int Ed Engl 2004;43:668-98.

Tracy M. Brya, Peter Baumann. G-Quadruplexes: From Guanine Gels to Chemotherapeutics. Mol Biotechnol 2011; 49:198â€“08.

Patel DJ, Phan AT, Kuryavyi V. Human telomere, oncogenic promoter and 5â€™-UTR G-quadruplexes: Diverse higher order DNA and RNA targets for cancer therapeutics. Nucleic Acids Res 2007;35:7429-55.

Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proc Natl Acad Sci U S A 2002;99:11593-8.

Grand CL, Han H, MuÃ±oz RM, Weitman S, Von Hoff DD, Hurley LH, et al. The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo. Mol Cancer Ther 2002;1:565-73.

Lu YJ, Ou TM, Tan JH, Hou JQ, Shao WY, Peng D, et al. 5-N-methylated quindoline derivatives as telomeric g-quadruplex stabilizing ligands: Effects of 5-N positive charge on quadruplex binding affinity and cell proliferation. J Med Chem 2008;51:6381-92.

Bejugam M, Sewitz S, Shirude PS, Rodriguez R, Shahid R, Balasubramanian S, et al. Trisubstituted isoalloxazines as a new class of G-quadruplex binding ligands: Small molecule regulation of c-kit oncogene expression. J Am Chem Soc 2007;129:12926-7.

Duan W, Rangan A, Vankayalapati H, Kim MY, Zeng Q, Sun D, et al. Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects. Mol Cancer Ther 2001;1:103-20.

Li Q, Xiang JF, Yang QF, Sun HX, Guan AJ, Tang YL, et al. G4LDB: A database for discovering and studying G-quadruplex ligands. Nucleic Acids Res 2013;41:D1115-23.

Chu B, Yuan G, Zhou J, Ou Y, Zhu P. A new telomerase inhibitor and apoptosis-inducing agent in leukemia: Perylene derivative as G-quadruplex ligand Tel03. Drug Dev Res 2008;69:235-41.

Read MA, Wood AA, Harrison JR, Gowan SM, Kelland LR, Dosanjh HS, et al. Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: Structure-activity relationships. J Med Chem 1999;42:4538-46.

Fedoroff OY, Salazar M, Han H, Chemeris VV, Kerwin SM, Hurley LH, et al. NMR-based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry 1998;37:12367-74.

Rossetti L, Franceschin M, Schirripa S, Bianco A, Ortaggi G, Savino M, et al. Selective interactions of perylene derivatives having different side chains with inter- and intramolecular G-quadruplex DNA structures. A correlation with telomerase inhibition. Bioorg Med Chem Lett 2005;15:413-20.

Franceschin M, Pascucci E, Alvino A, Dâ€™Ambrosio D, Bianco A, Ortaggi G, et al. New highly hydrosoluble and not self-aggregated perylene derivatives with three and four polar side-chains as G-quadruplex telomere targeting agents and telomerase inhibitors. Bioorg Med Chem Lett 2007;17:2515-22.

Franceschin M, Lombardo CM, Pascucci E, Dâ€™Ambrosio D, Micheli E, Bianco A, et al. The number and distances of positive charges of polyamine side chains in a series of perylene diimides significantly influence their ability to induce G-quadruplex structures and inhibit human telomerase. Bioorg Med Chem 2008;16:2292-304.